|
Alzheimer's disease
Citations 441-450 of 576 total displayed.
|
Past content
(since Jan 2001):
|
- BRIEF COMMUNICATIONS
Differential activation on fMRI of monozygotic twins discordant for AD
- A. M. Lipton, R. McColl, C. M. Cullum, G. Allen, W. K. Ringe, F. J. Bonte, E. McDonald, and C. D. Rubin
Neurology 2003; 60: 1713-1716.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Natural history of cognitive decline in the old old
- D. B. Howieson, R. Camicioli, J. Quinn, L. C. Silbert, B. Care, M. M. Moore, A. Dame, G. Sexton, and J. A. Kaye
Neurology 2003; 60: 1489-1494.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease
- P. Giannakopoulos, F. R. Herrmann, T. Bussière, C. Bouras, E. Kövari, D. P. Perl, J. H. Morrison, G. Gold, and P. R. Hof
Neurology 2003; 60: 1495-1500.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
A survey of voter participation by cognitively impaired elderly patients
- Brian R. Ott, William C. Heindel, and George D. Papandonatos
Neurology 2003; 60: 1546-1548.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Acute necrotizing encephalopathy of childhood with radiographic progression over 10 hours
- Alexander G. Bassuk, Delilah M. Burrowes, and Wes McRae
Neurology 2003; 60: 1552-1553.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Estrogen exposures and memory at midlife: A population-based study of women
- V.W. Henderson, J.R. Guthrie, E.C. Dudley, H.G. Burger, and L. Dennerstein
Neurology 2003; 60: 1369-1371.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Comparison of Alzheimer’s disease risk factors in white and African American families
- D. L. Bachman, R. C. Green, K. S. Benke, L. A. Cupples, and L. A. Farrer
Neurology 2003; 60: 1372-1374.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer’s disease?
- G. Chételat, B. Desgranges, V. de la Sayette, F. Viader, F. Eustache, and J.-C. Baron
Neurology 2003; 60: 1374-1377.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
DHEA for Alzheimer’s disease: A modest showing by a superhormone
- David Knopman and Victor W. Henderson
Neurology 2003; 60: 1060-1061.
[Full text]
[PDF]
- ARTICLES
DHEA treatment of Alzheimer’s disease: A randomized, double-blind, placebo-controlled study
- O.M. Wolkowitz, J.H. Kramer, V.I. Reus, M.M. Costa, K. Yaffe, P. Walton, M. Raskind, E. Peskind, P. Newhouse, D. Sack, E. De Souza, C. Sadowsky, E. Roberts, and the DHEA-Alzheimer’s Disease Collaborative Research Group
Neurology 2003; 60: 1071-1076.
[Abstract]
[Full text]
[PDF]
|
|
